Stocks · Health care · Pharmaceutical Preparations

Tyra Biosciences, Inc.

TYRA Clue Score32

United States Fiscal year ends December CIK 0001863127 Results filed 4 Aug 2026

Add to watchlist

By person

11 insiders · 15 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Robert J More

Director

—

$5.25M (2) scheduled

−$5.25M

3,823,425

6.41%

$78.68M

−6.3%

Daniel Bensen

Chief Discovery Officer

—

$4.81M (11) scheduled

−$4.81M

146,981

0.2463%

$3.02M

−65.7%

Gilla Kaplan

Director

—

$528.51K (1) scheduled

−$528.51K

28,231

0.0473%

$580.95K

−85.6%

Rehan Verjee

Director

$20.00K (1)

—

+$20.00K

972

0.0016%

$20.00K

—

Ra Capital Management, L.p. entity

Director

—

10,259,291

17.19%

$211.12M

+37.2%

Todd Harris

President and CEO

—

1,438,495

2.41%

$29.60M

+6.1%

Nina S Kjellson

Director

—

443,885

0.7438%

$9.13M

−20.6%

Alan Fuhrman

Chief Financial Officer

—

37,115

0.0622%

$763.77K

+188.9%

Douglas J Warner

Chief Medical Officer

—

25,000

0.0419%

$514.46K

—

Bhavesh Ashar

Chief Operating Officer

—

15,013

0.0252%

$308.94K

—

Yuliya Rueb

Vice President, Finance (PAO)

—

11,258

0.0189%

$231.67K

—

Tyra Biosciences, Inc.

What the insiders did Mostly scheduled

By person